Used primarily in scientific research to study peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) pathways. It acts as a selective antagonist, helping to block PPARβ/δ activity, which allows researchers to investigate the receptor's role in metabolism, inflammation, and cell differentiation. Commonly applied in studies related to metabolic diseases, cancer, and cardiovascular function. Due to its specificity, it is a valuable tool in developing potential therapies targeting PPAR receptors. Not intended for clinical use in humans.